PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.18%
Positive revenue growth while WEED.TO is negative. John Neff might see a notable competitive edge here.
-22.45%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-866.94%
Negative EBIT growth while WEED.TO is at 57.88%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-866.94%
Negative operating income growth while WEED.TO is at 57.88%. Joel Greenblatt would press for urgent turnaround measures.
-1775.75%
Negative net income growth while WEED.TO stands at 22.60%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-1785.39%
Negative EPS growth while WEED.TO is at 23.87%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-1785.39%
Negative diluted EPS growth while WEED.TO is at 23.87%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
11.26%
Share count expansion well above WEED.TO's 1.67%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
11.07%
Diluted share count expanding well above WEED.TO's 1.50%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
90.83%
Positive OCF growth while WEED.TO is negative. John Neff would see this as a clear operational advantage vs. the competitor.
68.66%
FCF growth above 1.5x WEED.TO's 6.12%. David Dodd would verify if the firm’s strategic investments yield superior returns.
No Data
No Data available this quarter, please select a different quarter.
4893.26%
5Y revenue/share CAGR above 1.5x WEED.TO's 678.24%. David Dodd would look for consistent product or market expansions fueling outperformance.
1224.22%
3Y revenue/share CAGR above 1.5x WEED.TO's 237.11%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-1227.10%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
15.30%
Positive OCF/share growth while WEED.TO is negative. John Neff might see a comparative advantage in operational cash viability.
-7393.93%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-5688.60%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-3007.60%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-1597.85%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
5422.95%
10Y equity/share CAGR above 1.5x WEED.TO's 1552.05%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
2128.90%
5Y equity/share CAGR above 1.5x WEED.TO's 643.54%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
211.19%
3Y equity/share CAGR above 1.5x WEED.TO's 55.62%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-37.46%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
13.05%
We show growth while WEED.TO is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-7.26%
Negative asset growth while WEED.TO invests at 8.15%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-14.39%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-17.06%
We’re deleveraging while WEED.TO stands at 105.68%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-21.64%
Our R&D shrinks while WEED.TO invests at 13.20%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
2.01%
SG&A declining or stable vs. WEED.TO's 32.93%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.